国泰中证生物医药ETF(512290)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/12/31 |
4,026,430,000 |
- |
4,040,950,000 |
4,034,960,000 |
100% |
2024/9/30 |
4,158,990,000 |
- |
4,192,460,000 |
4,181,950,000 |
99% |
2024/6/30 |
3,584,960,000 |
- |
3,609,340,000 |
3,605,760,000 |
99% |
2024/3/31 |
3,986,130,000 |
- |
3,999,550,000 |
3,994,360,000 |
100% |
2023/12/31 |
4,661,060,000 |
- |
4,680,980,000 |
4,673,890,000 |
100% |
2023/9/30 |
5,310,880,000 |
- |
5,332,710,000 |
5,322,900,000 |
100% |
2023/6/30 |
5,558,100,000 |
- |
5,579,190,000 |
5,568,570,000 |
100% |
2023/3/31 |
5,153,920,000 |
- |
5,173,200,000 |
5,163,370,000 |
100% |
2022/12/31 |
3,937,280,000 |
- |
3,964,770,000 |
3,953,230,000 |
100% |
2022/9/30 |
4,059,570,000 |
- |
4,083,860,000 |
4,070,210,000 |
100% |
2022/6/30 |
3,722,080,000 |
- |
3,743,890,000 |
3,731,820,000 |
100% |
2022/3/31 |
3,425,370,000 |
- |
3,448,590,000 |
3,443,510,000 |
99% |
2021/12/31 |
3,909,250,000 |
- |
3,929,760,000 |
3,921,760,000 |
100% |
2021/9/30 |
2,888,090,000 |
- |
2,946,740,000 |
2,917,710,000 |
99% |
2021/6/30 |
2,612,150,000 |
- |
2,649,550,000 |
2,641,000,000 |
99% |
2021/3/31 |
3,337,720,000 |
1,463,000 |
3,364,200,000 |
3,357,760,000 |
99% |
2020/12/31 |
4,158,430,000 |
3,498,900 |
4,203,680,000 |
4,190,820,000 |
99% |
2020/9/30 |
4,031,860,000 |
- |
4,085,310,000 |
4,068,180,000 |
99% |
2020/6/30 |
2,245,090,000 |
- |
2,285,890,000 |
2,264,650,000 |
99% |
2020/3/31 |
977,821,000 |
86,000 |
1,011,530,000 |
1,003,950,000 |
97% |
2019/12/31 |
496,929,000 |
- |
503,918,000 |
501,953,000 |
99% |
2019/9/30 |
381,362,000 |
- |
386,736,000 |
384,853,000 |
99% |
2019/6/30 |
589,219,000 |
- |
613,410,000 |
596,933,000 |
99% |
2019/5/13 |
201,884,000 |
- |
456,013,000 |
455,721,000 |
44% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。